RNA is no longer a modality. It is becoming infrastructure.
We stand at an inflection point. RNA is no longer just a molecule of interest or a novel therapeutic modality-itis rapidly becoming the foundationaloperating systemfor a new era of programmable medicine. From the rapid global deployment of mRNA vaccines to the precise, durable silencing of disease-causing genes, RNA hasdemonstrated its power not as a single technology, but as a versatile platform for writing and executingbiological instructions.
Yet, with this promise comes profound complexity. The journey from Code to Cure is not a linear path. It is a systems engineering challenge of the highest order, where exquisite sequence design can fail without the right delivery engine, and where a potent therapeutic effect in cells must be reconciled with the realities of human immunology, scalable manufacturing, and equitable access.
RNA World 2026 is designed to confront this systems challenge
Scientific Advisory Board
How the system is structured
RNA medicine is not built linearly. It is a system composed of three interdependent layers: